We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
Cap. Flow
+$859M
Cap. Flow %
5.88%
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.3M
2
AMGN icon
Amgen
AMGN
+$88.7M
3
ALL icon
Allstate
ALL
+$52.2M
4
UNP icon
Union Pacific
UNP
+$47.1M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 33.42%
2 Technology 23.2%
3 Consumer Discretionary 9.14%
4 Financials 8.63%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REMX icon
701
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.03B
$988K 0.01%
+11,630
New +$941K
INVH icon
702
Invitation Homes
INVH
$17.6B
$961K 0.01%
25,784
MRO
703
DELISTED
Marathon Oil Corporation
MRO
$960K 0.01%
70,479
-338,161
-83% -$4.09M
EXR icon
704
Extra Space Storage
EXR
$31.3B
$955K 0.01%
5,827
-926
-14% -$139K
VNO icon
705
Vornado Realty Trust
VNO
$7.43B
$954K 0.01%
20,447
-13,012
-39% -$608K
WYNN icon
706
Wynn Resorts
WYNN
$10.3B
$933K 0.01%
7,629
-1,586
-17% -$202K
VER
707
DELISTED
VEREIT, Inc.
VER
$929K 0.01%
20,218
+3,840
+23% +$174K
ITUB icon
708
Itaú Unibanco
ITUB
$92.3B
$924K 0.01%
211,186
-88,693
-30% -$357K
LW icon
709
Lamb Weston
LW
$7.3B
$924K 0.01%
11,455
+1,501
+15% +$120K
ARKK icon
710
ARK Innovation ETF
ARKK
$5.74B
$923K 0.01%
7,060
+710
+11% +$82.8K
WHR icon
711
Whirlpool
WHR
$2.44B
$916K 0.01%
4,203
+660
+19% +$154K
TYL icon
712
Tyler Technologies
TYL
$13B
$903K 0.01%
1,996
-378
-16% -$161K
LUMN icon
713
Lumen
LUMN
$6.45B
$900K 0.01%
+66,231
New +$914K
ACGL icon
714
Arch Capital
ACGL
$36.3B
$881K 0.01%
22,622
-2,994
-12% -$119K
HWM icon
715
Howmet Aerospace
HWM
$115B
$861K 0.01%
24,980
-7,987
-24% -$266K
LYV icon
716
Live Nation Entertainment
LYV
$41.7B
$855K 0.01%
9,760
-62,593
-87% -$5.37M
DISCK
717
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$852K 0.01%
29,404
-15,056
-34% -$468K
BR icon
718
Broadridge
BR
$17.7B
$849K 0.01%
5,257
-11,912
-69% -$1.9M
XPO icon
719
XPO
XPO
$24.4B
$845K 0.01%
17,476
+2,822
+19% +$138K
NTR icon
720
Nutrien
NTR
$32.4B
$839K 0.01%
13,835
-535
-4% -$31.7K
RSG icon
721
Republic Services
RSG
$66.7B
$836K 0.01%
7,599
-10,108
-57% -$1.09M
ELS icon
722
Equity Lifestyle Properties
ELS
$12.6B
$822K 0.01%
11,073
-1,173
-10% -$83K
MKL icon
723
Markel Group
MKL
$25.2B
$822K 0.01%
693
-118
-15% -$141K
PKG icon
724
Packaging Corp of America
PKG
$22.5B
$821K 0.01%
6,059
-92,385
-94% -$13.3M
BBD icon
725
Banco Bradesco
BBD
$38.5B
$811K 0.01%
173,811
-133,886
-44% -$582K

Similar funds

Candriam SCA's Q2 2021 Portfolio in Review

As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.

  • Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
  • Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
  • Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
  • Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
  • Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
  • Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.